CABG | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'CABG'

UPDATED on 12/26/2020 – CABG: a Superior Revascularization Modality to PCI in Patients with poor LVF, Multivessel disease and Diabetes, Similar Risk of Stroke between 31 days and 5 years, post intervention

Posted in Atherogenic Processes & Pathology, Bio Instrumentation in Experimental Life Sciences Research, CABG, Cardiac and Cardiovascular Surgical Procedures, Cerebrovascular and Neurodegenerative Diseases, Frontiers in Cardiology and Cardiovascular Disorders, Left Main Coronary Artery Disease (LMCAD), Origins of Cardiovascular Disease, PCI, Stroke on July 25, 2018| Leave a Comment »

UPDATED on 12/26/2020 – CABG: a Superior Revascularization Modality to PCI in Patients with poor LVF, Multivessel disease and Diabetes, Similar Risk of Stroke between 31 days and 5 years, post intervention Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 12/26/2020 Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease List of authors. […]

Read Full Post »

Cardiac Surgery Recommendations Switch to Patient Blood Management

Posted in Aortic Valve: TAVR, TAVI vs Open Heart Surgery, CABG, Cardiac and Cardiovascular Surgical Procedures, Heart Transplant, Heart-Lung Transplant, Implantation, Mitral Valve: Repair and Replacement on July 8, 2021| Leave a Comment »

Cardiac Surgery Recommendations Switch to Patient Blood Management — Four societies outline pre- to post-op strategies to improve outcomes by Crystal Phend, Contributing Editor, MedPage Today June 30, 2021 Reporter: Aviva Lev-Ari, PhD, RN STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management Pierre Tibi, MD R. Scott McClure, MD, FRCSC Jiapeng Huang, MD Scott […]

Read Full Post »

PCI, CABG, CHF, AMI – Two Payment Methods: Bundled payments (hospitalization costs, up to 90 days of post-acute care, nursing home care, complications, and rehospitalizations) vs Diagnosis-related groupings cover only what happens in the hospital.

Posted in Centers for Medicare & Medicaid Services, Health Care System by Country, Health Economics and Outcomes Research, HealthCare IT, Hospital-based Medical Innovations, United States on July 10, 2018| Leave a Comment »

PCI, CABG, CHF, AMI – Two Payment Methods: Bundled payments (hospitalization costs, up to 90 days of post-acute care, nursing home care, complications, and rehospitalizations) vs Diagnosis-related groupings cover only what happens in the hospital. Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 8/17/2018 Certain risk factors make survivors of an acute MI more likely […]

Read Full Post »

Single-Author Curations by Aviva Lev-Ari, PhD, RN on MedTech (Cardiac Imaging) and Cardiac and Cardiovascular Medical Devices

Posted in on August 6, 2018|

Curations on MedTech (Cardiac Imaging) and Cardiac and Cardiovascular Medical Devices in use for Cardiac Surgery, Cardiothoracic Surgical Procedures and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty Single-Author Curations by Aviva Lev-Ari, PhD, RN On 8/13/2018 Curations, N = 41 42c Experimental Therapy (Left inter-atrial shunt implant device) for Heart Failure: Expert Opinion on […]

Read Full Post »

Coronary Artery Interventions: Balloon, Stent, Drug-eluting Stent and Antiplatelet Demand

Posted in Academic Publishing, CABG, Cardiac and Cardiovascular Surgical Procedures, Cardiovascular Pharmacogenomics, PCI, tagged bare metal stents (BMS), drug-coated balloon (DCB), drug-eluting stent (DES), Keywords: In-stent restenosis (ISR), paclitaxel-eluting balloon (PEB), stent thrombosis (ST) on August 5, 2018| Leave a Comment »

UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active The FDA approved the first ultrathin strut drug-eluting stent, Orsiro, as well as a shelf-stable, premixed vancomycin injection for infective endocarditis and other indications. UPDATED on 3/16/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active Dual antiplatelet therapy with ticagrelor (Brilinta) reduced major adverse cardiovascular events in type 2 diabetes patients with coronary artery disease but no prior heart attack or […]

Read Full Post »

Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients

Posted in CABG, Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, PCI, Peripheral Arterial Disease & Peripheral Vascular Surgery, Pharmacotherapy of Cardiovascular Disease, Stroke on November 20, 2019| Leave a Comment »

Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients Reporter: Aviva Lev-Ari, PhD, RN Genotyping Cardiac Patients May Reduce Risks From DAPT -STEMI patient study reaches noninferiority mark for adverse cardiac events by Vicki Brower, CME Writer, MedPage Today September 7, 2019 In the investigational arm, all 1,242 patients were tested […]

Read Full Post »

2017 American Heart Association Annual Meeting: Sunday’s Science at #AHA17 – Presidential Address

Posted in Frontiers in Cardiology and Cardiovascular Disorders on November 13, 2017| Leave a Comment »

2017 American Heart Association Annual Meeting: Sunday’s Science at #AHA17 – Presidential Address Reporter: Aviva Lev-Ari, PhD, RN WATCH VIDEOS http://professional.heart.org/professional/EducationMeetings/MeetingsLiveCME/ScientificSessions/UCM_316934_Science-News-Scientific-Sessions.jsp#vid-ss17-open1 Best of Sunday at Scientific Sessions 2017 • TRiCS III – What differences were seen in cardiac surgery outcomes with restrictive red cell transfusion vs a more liberal strategy? • DACAB – […]

Read Full Post »

Co-Curation Articles on MedTech and Cardiovascular Medical Devices by LPBI Group’s Team Members and Aviva Lev-Ari, PhD, RN

Posted in on August 6, 2018|

Co-Curation Articles on MedTech and Cardiovascular Medical Devices by LPBI Group’s Team Members and Aviva Lev-Ari, PhD, RN On 8/13/2018 Co-Curations by LPBI Team Members and Aviva Lev-Ari, PhD, RN N = 51 67co ATP – the universal energy carrier in the living cell: Reflections on the discoveries and applications in Medicine Curators: Larry H. Bernstein, MD, FCAP […]

Read Full Post »

Left Main Coronary Artery Disease (LMCAD): Stents vs CABG – The less-invasive option is Equally Safe and Effective

Posted in Left Main Coronary Artery Disease (LMCAD) on December 6, 2016| Leave a Comment »

Left Main Coronary Artery Disease (LMCAD): Stents vs CABG – The less-invasive option is Equally Safe and Effective Reporter: Aviva Lev-Ari, PhD, RN Original Article in NEJM http://www.nejm.org/doi/pdf/10.1056/NEJMoa1610227 Based on Stents, Bypass Surgery Equally Safe and Effective for Many with Left Main Heart Disease – Stents offer less-invasive option for many patients with left main […]